Kidney Cancer Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

Topics: Renal cell carcinoma, Marketing, Cancer Pages: 13 (2266 words) Published: March 12, 2015
Transparency Market
Research
Kidney Cancer Drugs Market - Global Industry Analysis,
Pipeline Analysis, Size, Share, Growth, Trends and
Forecast 2014 - 2020

Published Date
2015-01-23

82 Page Report

Buy Now

Request Sample

Press Release

Kidney Cancer Drugs Market Expected to Reach USD 4.5 Billion Globally in 2020
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com

Kidney Cancer Drugs Market

REPORT DESCRIPTION

Kidney Cancer Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

According to a new market report published by Transparency Market Research “Kidney Cancer Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”, the global kidney cancer drugs market was valued at USD 2.6 billion in 2013 and is expected to reach USD 4.5 billion in 2020, growing at a CAGR of 6.6% from 2014 to 2020.

Kidney cancer or renal cell carcinoma (RCC) is one of the common urologic tumors accounting for around 3% of all human malignancies. The incidence rate of renal cell carcinoma has increased progressively in the recent decades. According to the American Cancer Society, about 61,500 newly diagnosed cases are expected to occur in the U.S. in 2015. Kidney cancer rates are expected to increase every year with reduction in physical activity, rise in obesity and smoking, etc., which leads to an unhealthy lifestyle and increased susceptibility to cancer. The global incidence of kidney cancer diagnosis has reportedly increased by 10% to 30% every decade since 1999. Thus, high incidence and prevalence rates of kidney cancer have helped this market to transform it into billion-dollar market.

Browse the full Kidney Cancer Drugs Market Report at :
http://www.transparencymarketresearch.com/kidney-cancer-drugsmarket.html

The global kidney cancer drugs market has been segmented based on the major branded drugs generally prescribed and used for the treatment of various types of kidney cancer such as Sutent (Sunitinib), Nexavar (Sorafenib), Afinitor (Everolimus), Votrient (Pazopanib), Inlyta (Axitinib), Avastin (Bevacizumab), Torisel (Temsirolimus) and Proleukin (Aldesleukin). In terms of revenue, Sutent accounted for the largest share of over 30% of the kidney cancer drugs market in 2013. However, the drug is expected to grow at a sluggish CAGR of 1.1% from 2012 to 2016 and a CAGR of 2.1% from 2016 to 2020. Sunitinib is a well-known drug and often used as the first-line

Transparency Market Research

2

Kidney Cancer Drugs Market

treatment for RCC. Sunitinib is among the most studied drugs in its class for multiple indications, as it targets multiple receptor tyrosine kinases (RTKs). However, the relatively high price of the drug has often been regarded as a serious drawback to the use of Sutent, although the drug has been considered the first-line treatment agent for RCC. Moreover, in terms of market growth Votrient is expected to witness the highest growth rate among all kidney cancer drugs during the forecast period. The drug is expected to witness a CAGR of 41.7% from 2012 to 2016 and a CAGR of 8.9% from 2016 to 2020. However, with the loss of patent exclusivity, generic drug variants would offer clinicians a broad range of affordable medications to prescribe, thereby significantly reducing the overall size of the kidney cancer drugs market to an extent. Hence, commercialization of novel molecules for treating diverse kidney cancers including renal cell carcinoma would govern the future market growth of the kidney cancer drugs market.

Get Free Sample Report Kidney Cancer Drugs Market :
http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=537

Potential pipeline drugs identified and expected to be launched during the forecast period...
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Markets: UK Potable Water Industry 2014, Global Industry Analysis, Size, Share, Growth, Trends and Forecast Research Paper
  • Market: US Frozen Snacks Market 2014, Global Industry Analysis, Size, Share, Growth, Essay
  • Global Construction Equipment Market
  • Tembotrione Market for Corn and Other Applications
  • Research on Optical Metrology Market
  • Essay on Research on Exanthema Market
  • Essay about Thiochemicals Market Global Industry Analysis Size Share Growth Trends And Forecast 2014 2020
  • Gold Potassium Cyanide Market Global Industry Analysis Size Share Growth Trends And Forecast 2014 2020 Essay

Become a StudyMode Member

Sign Up - It's Free